Subscribe to Newsletter

Business & Profession

Business & Profession Cornea / Ocular Surface

Two-Tap Amblyopia Screening

| David Huang, Joannah Vaughan

With childhood vision disorders like amblyopia and strabismus, early diagnosis is the key to treatment success.

Business & Profession Professional Development

Big Data in Medicine and Ophthalmology

| Pete Sudbury

Big data analytics is the most sophisticated method yet devised for “augmenting the human intellect”.

Business & Profession Retina

Heads Up!

| Mark Hillen

A head-mounted iPhone-based ophthalmoscope is the latest step in the rapidly evolving world of smartphone fundoscopy

Business & Profession Professional Development

This Month in Business

| Mark Hillen

Valeant and Allergan continue to joust, Santen purchases MSD’s ophthalmology drug portfolio in selected markets, and Kala completes a US$22.5 million Series B financing round

Business & Profession Professional Development

Ophthotech's Billion Dollar Baby

| Mark Hillen

Purchase of the ex-US rights for Fovista is costing Novartis US$200 million down and up to a cool US$1 billion in milestone payments

Business & Profession Business and Innovation

Killer Apps and Game-Changers

| Mark Hillen

At last, a unique and useful function for femtosecond laser systems has emerged.

Business & Profession Cornea / Ocular Surface

Beaming for Better Cross Linking

| David Geffen, Paul Karpecki

Increasing the light intensity over the thinnest point of the cornea – the periphery –improves outcomes of corneal collagen cross-linking in keratectasia patients.

Business & Profession Refractive

How to Reduce Higher-Order Aberrations

A new technology that measures subjective refraction based on point spread function targets generates better data, increases efficiency in the clinic and improves patient outcomes.

Business & Profession Other

The Uniqueness of Uveal Melanoma

| Takami Sato , Carol Shields

Uveal and skin melanoma originate in the same type of cell, but are very different in terms of molecular mechanism, pathobiology, prognosis and therapeutic strategy. Here, the features of uveal melanoma are described and the latest therapeutic developments discussed.

Business & Profession Professional Development

Regrets, I’ve Had a Few…

| Mark Hillen

If you had your time again, would you go to medical school, and would you choose ophthalmology?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: